Inspire Medical Systems (INSP) Common Equity (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Common Equity data on file, last reported at $792.3 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 24.63% year-over-year to $792.3 million; the trailing twelve-month figure through Mar 2026 stood at $792.3 million (up 24.63% YoY), and the FY2025 full-year result was $781.2 million, up 13.26% from the prior year.
• Common Equity rose to $792.3 million in Q1 2026, from $781.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $792.3 million in Q1 2026 to a low of $225.1 million in Q1 2022.
• A 5-year average of $572.7 million and a median of $589.0 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 133.21% in 2023 and dropped 4.32% in 2025, its largest moves.
• Tracing INSP's Common Equity over 5 years: stood at $496.0 million in 2022, then gained by 15.42% to $572.5 million in 2023, then gained by 20.47% to $689.7 million in 2024, then gained by 13.26% to $781.2 million in 2025, then grew by 1.43% to $792.3 million in 2026.
• Business Quant data shows INSP's Common Equity at $792.3 million in Q1 2026, $781.2 million in Q4 2025, and $666.5 million in Q3 2025.